If we can’t see race and ethnicity in research, how will we see racial inequality?
This Comment article supports SDGs 3, 10, and 17 by highlighting the need for full inclusivity and representation, and the involvement of a diverse range of stakeholders and voices, in order to successfully design solutions to global health problems and to reform the systems that are exacerbating global health inequities.
Open Access (OA) and the advent of access programs such as Research4Life have rapidly transformed the publishing landscape. In some ways, they have made strides in bridging the knowledge gap between high- and low-income countries. In other ways, they may present obstacles, so it’s important to ensure that a move towards open access doesn’t disadvantage low-income countries.This article contributes to SDGs 10 and 17.
This chapter advances the UN SDG goal 3 and 17 in understanding Alzheimer's disease at the cellular level
This chapter advances the UN SDG goal 3 and 17 in exploring the link between metabolites of shikimate pathway and Alzheimer disease
In this episode of the “World We Want” podcast series, RELX’s Global Head of Corporate Responsibility, Dr. Márcia Balisciano, talks to Irina Bokova about leadership.
An Article in support of SDGs 3 and 17, analysing the extent to which the budgets of The Global Fund to Fight AIDS, Tuberculosis and Malaria support health security, highlighting the importance of disease-specific global health initiatives to support health security efforts and to respond to current and future pandemics.
In this conversation of the “World We Want” podcast series, RELX’s Global Head of Corporate Responsibility, Dr Márcia Balisciano, talks to Dr. Shola Mos-Shogbamimu about leadership.
In this third conversation of the “World We Want” podcast series, RELX’s Global Head of Corporate Responsibility, Dr Márcia Balisciano, talks to Dr. Heinz Fischer about leadership.
A Review, in support of SDGs 3 and 17, summarising the efforts of a target product profile working group formed after the Sunnylands Summit: The Path Toward Ending HIV, in Feb 7–9, 2019, to develop target product profiles for HIV curative interventions.
